BlackRock Institutional Trust’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$53.7M Buy
974,021
+165,762
+21% +$9.1M 0.01% 1301
2016
Q3
$45.7M Buy
808,259
+137,421
+20% +$6.74M 0.01% 1356
2016
Q2
$28M Buy
670,838
+171,349
+34% +$7.89M ﹤0.01% 1620
2016
Q1
$21.4M Buy
499,489
+3,647
+0.7% +$154K ﹤0.01% 1781
2015
Q4
$22.4M Buy
495,842
+31,706
+7% +$1.33M ﹤0.01% 1788
2015
Q3
$18M Sell
464,136
-120,856
-21% -$4.84M ﹤0.01% 1908
2015
Q2
$21.3M Buy
584,992
+144,476
+33% +$4.57M ﹤0.01% 1884
2015
Q1
$12.7M Buy
440,516
+226,277
+106% +$6.31M ﹤0.01% 2235
2014
Q4
$5.19M Buy
+214,239
New +$4.83M ﹤0.01% 2718

Other funds holding PRAH

BlackRock Institutional Trust's PRAH Position: Q4 2016 in Review

BlackRock Institutional Trust increased its PRA Health Sciences, Inc. (PRAH) stake by 21% in Q4 2016, buying an estimated $9.1M and bringing the position to 974,021 shares worth $53.7M. The position accounts for 0.01% of the portfolio, ranked #1301.

BlackRock Institutional Trust first reported a position in PRAH in Q4 2014 and has held it in 9 quarters since. 188 funds tracked by Wall St. Rank hold PRAH as of Q4 2016.

  • BlackRock Institutional Trust held 974,021 shares of PRA Health Sciences, Inc. worth $53.7M as of Q4 2016.
  • BlackRock Institutional Trust bought 165,762 PRA Health Sciences, Inc. shares in Q4 2016, an estimated $9.1M.
  • PRA Health Sciences, Inc. made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1301 holding.
  • BlackRock Institutional Trust first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 9 quarters since.
  • 188 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.